From 2023 to 2033, the global antimicrobial wound care dressings market is estimated to be worth US$ 1.38 billion, with a CAGR of 6.4%. The global antimicrobial wound dressings market is expected to reach US$ 2.57 billion by 2033.
Antimicrobial wound healing dressings are specialty dressings that consist of medicines that benefit in the healing of wound infections. These dressings act as a barrier against bacteria that could penetrate the wound and cause infection. An upward trend in the prevalence of acute wounds, an upsurge in surgical cases, and traumatic wounds spur the antimicrobial dressings market.
Antimicrobial wound dressings contain antibacterial compounds derived from animals, biologics, or pharmaceuticals. These dressings limit the development of microorganisms and bacterial penetration into the wound. Silver, iodine, chlorhexidine, polyhexamethylbiguanide (PHMB), alginate, and hydrocolloids are antiseptics used in antimicrobial dressings.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Between 2018 and 2022, the global antimicrobial wound care dressings market grew at a sluggish CAGR of 3.4%. The antimicrobial dressings market reached US$ 1.3 billion in 2022, up from US$ 1.14 billion in 2018. The antimicrobial wound care dressings market is expected to reach US$ 2.57 billion by 2033, with a 6.4% CAGR from 2023 to 2033.
Many interconnected factors affect important processes during the physiological process of wound healing. Although many superficial wounds heal normally, some do not, which can lead to infectious and chronic wounds. Wound management is a critical global challenge that imposes a high cost on patients and healthcare systems.
Due to a better understanding of the wound healing process and technological improvements, there have been significant advances in wound treatment. Some examples are advanced fabrics with intrinsic bactericidal activity, integrated antimicrobial compounds, and smart systems that aid wound healing.
Dressings derived from natural and synthetic sources are gaining popularity at the moment. Plant extracts have been successfully tested in injectable forms for adult stem cell therapies, and they have been demonstrated to be useful in skin regeneration when placed in dressings.
Proteolytic enzymes regulate various metabolic activities, including immune response and cell division. Exogenous caspase was the first enzymatic treatment utilized to treat chronic wounds. Advanced wound products are used frequently due to the spike in burn and trauma cases leading to the antimicrobial dressing’s market expansion. Product innovation and acquisition are the key strategies companies use to increase their market share and antimicrobial wound care dressings sales in the advanced wound dressing sector.
| Attributes | Details |
|---|---|
| Antimicrobial Wound Care Dressings Market CAGR (From 2023 to 2033) | 6.4% |
| Antimicrobial Wound Care Dressings Market HCAGR (From 2018 to 2022) | 3.4% |
| Antimicrobial Wound Care Dressings Market Size (2018) | US$ 1.14 billion |
| Antimicrobial Wound Care Dressings Market Size (2022) | US$ 1.3 billion |
| Antimicrobial Wound Care Dressings Market Size (2023) | US$ 1.38 billion |
| Antimicrobial Wound Care Dressings Market Size (2033) | US$ 2.57 billion |
Chronic wounds, such as venous leg ulcers, pressure ulcers, and diabetic foot ulcers, are becoming common, particularly in developing nations. The incidence of wounds has increased due to the high prevalence of co-morbid illnesses and the lack of diagnosis in the patient population for chronic wounds.
In 2018, 240 million persons in the Asia Pacific region had diabetes. This represents an estimated 60% of the world's diabetes population. According to statistics, 34% of diabetics are at risk of developing foot ulcers in their lifetime.
The prevalence of pressure ulcers and other wounds is increasing the demand for sophisticated dressings for treating these wounds. Due to the low cost of managing wound dressings, the development of novel wound dressings with exudate management and infection control accelerated adoption.
Principal Consultant
Due to their demonstrated clinical efficiency in wound care over the film, foam, and other dressings, the demand for antimicrobial wound care dressings is increasing. This signaled a change from conventional wound dressings like bandages and other items to cutting-edge wound dressings.
To take advantage of the lucrative possibilities, antimicrobial wound care dressings manufacturers are constantly working to develop and introduce new, advanced dressings with proven clinical efficacy.
High antimicrobial wound care dressings demand on the global market have been primarily attributed to technological developments in wound dressings and the soaring incidence of chronic wounds.
A higher prevalence of diabetic foot ulcers has been directly linked to rising diabetes prevalence. Patients with diabetes, especially type-2 diabetics, have a significantly increased risk of developing a foot ulcer. The fact that type-2 diabetes is the most common type of diabetes worldwide raises serious concerns for healthcare systems all over the world.
Diabetes patients, particularly those in emerging economies, frequently go without receiving a diagnosis for foot ulcers. The detection of foot ulcers has been hampered in these nations by low awareness of foot ulcer complications and inadequate reimbursement frameworks.
Advanced wound care dressing sales have been hampered due to the small number of patients receiving treatment and the large population still staying undiagnosed. The patients seeking or maintaining treatment for chronic wounds are constrained due to reduced healthcare spending per capita and high out-of-pocket costs. Due to these constraints, the antimicrobial wound care dressings market developing areas have had difficulty implementing innovative wound dressing solutions.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Attributes | Details |
|---|---|
| Silver Wound Dressings Segment Share | 39.5% |
| Povidone-Iodine Wound Dressings CAGR | 6.5% |
In 2023, the silver wound dressings segment to make up 39.5% of the antimicrobial wound care dressings market share. Silver wound dressings are antimicrobial wound care dressings using silver as the active element. The dressings function by releasing silver ions, which aid in the killing or inhibition of microbial development in the wound bed.
Silver wound dressings are beneficial in the treatment of chronic wounds that are prone to infection, such as pressure ulcers and diabetic foot ulcers. They are used to lower the risk of infection and promote quick healing in surgical incisions.
Out of the 266 million surgeries conducted worldwide each year, 0.5% to 3.0% of patients may develop surgical site infections.
The demand for silver wound dressings may rise as silver dressings aid in the treatment of infections and wounds.
The sector for povidone-iodine wound dressings is expected to develop at a 6.5% CAGR over the forecast period. Infected wounds such as surgical wounds, burns, and pressure ulcers can be treated with these. They are used to stop infections from spreading to fresh surgical wounds. There are many people who are developing chronic wounds like pressure ulcers.
More than 2.5 million people in America suffer from pressure ulcers each year. Nearly, 12.7% of pressure ulcers occur worldwide on an annual basis. Over the projected period, this is anticipated to lead to an increase in the usage of povidone-iodine dressings.
| Attributes | Details |
|---|---|
| Chronic Wounds Segment Share | 59.8% |
| Acute Wounds Segment CAGR | 6.5% |
With a market share of 59.8% in 2023, the chronic wounds category is predicted to lead the market by application. The prevalence of chronic wounds including pressure ulcers, venous leg ulcers, diabetic foot ulcers, and other chronic wounds might be blamed for the domination.
Such wounds require long healing times, which may lead to an increase in the usage of antimicrobial wound care dressings, driving the segment's expansion.
The category for acute wounds is to increase quickly, 6.5%, during the anticipated period. The rising rate can be attributed to an increase in surgical cases as well as an increase in burn and traumatic incidents. As the frequency of surgeries rises, so do the instances of surgical site infections.
For instance, according to the National Healthcare Safety Network's surgical site infections surveillance, the United States reported over 157,500 instances of SSI in 2018. The demand for antimicrobial wound care dressings is to rise as they aid in the healing of such surgical sites, driving the segment's expansion.
| Attributes | Details |
|---|---|
| Hospitals Segment Share | 45.2% |
| Home Care Segment CAGR | 7.1% |
With a market share of 45.2% in 2023, the hospital sector controlled the majority of the antimicrobial wound care dressings market. This can be attributed to the growing hospital industry, rising surgical rates, and growing patient populations across all age groups.
The number of procedures is anticipated to rise along with the number of hospitals. The use of antimicrobial wound care dressings in hospital settings may be increased as a result of surgical site infections, which might assist the segment rule the market during the next years.
Over the forecast period, the home care segment is expected to increase at a robust CAGR of 7.1%. The number of home care settings has increased in several nations. Several surgical treatments have lengthy recovery times, necessitating many changes to the wound dressing. The demand for home care rises as the aging and obese population grow. For instance, obesity rates worldwide have tripled since 1975, according to statistics provided by the WHO. This might increase demand for in-home care facilities.
| Attributes | Details |
|---|---|
| North America Market Share | 45.4% |
| Asia Pacific Market CAGR | 7.1% |
The antimicrobial wound care dressings market is to be dominated by North America in 2023, accounting for 45.4% of global antimicrobial wound care dressings sales. The existence of significant market participants, an increase in surgical procedures, and a rise in target populations can be considered as causes.
The prevalence of chronic diseases and an increase in surgical cases in the Asia Pacific region may both contribute to a growth in antimicrobial wound care dressings demand. According to the Australian Institute of Health and Welfare, 623,000 persons who were on the waiting list at public hospitals were admitted for surgery. There were 784,000 more patients waiting for elective treatments.
Antimicrobial wound care dressings may be in demand due to an increase in hospitalizations during the forecast period.
Development of the Healthcare System and High Disease Prevalence
In 2023, the United States held around 94.0% of the antimicrobial wound care dressings market in North America.
Due to factors like a sizable aging population, rising wound and injury rates, and a high incidence of diabetes, the antimicrobial wound dressing market is anticipated to expand in the United States. The country's market is expected to grow as a result of escalating healthcare expenditures and broadening government assistance and reimbursement programs for goods.
Increasing Awareness Initiatives on Wound Care and Its Effect on Health Systems
In 2023, Germany's antimicrobial wound care dressings market share in Europe was almost 25.5%.
A working group of Voice of the Medical Technology Industry in Europe is called Advanced Wound Care Sector Group (Eucomed). The European Wound Management Association, the industry's clinical voice works closely together.
Their goal is to increase patient safety and wound quality. They hope to highlight the significant effects that wounds have on both patients and medical professionals. These organizations intend to encourage consumers in Germany to ship internationally.
Rising Disposable Income and Growing Domestic Sales of Wound Care Goods
In 2023, China owned a market share of around 45.7% of the East Asian market. Due to increased local demand and dwindling export markets, China's market is shifting from an export-focused to a domestic sales-focused business. The share of antimicrobial dressing sales has increased, as has the number of export-focused enterprises entering the domestic market.
The advanced wound care dressing market is expected to increase in China as disposable income rises and medical physicians become more aware of the benefits of these dressings.
Major Participants Concentrating on Research and Development to Launch New Goods in the Industry
Several regional and international businesses are participating in the antimicrobial wound dressings market, which is semi-consolidated. A solid distribution network and a varied variety of dressings have helped several antimicrobial wound dressings manufacturers gain traction in the local markets
Three companies-3M, Smith & Nephew, and ConvaTec, Inc.-rule the world antimicrobial wound dressings market. These competitors place a significant and varied emphasis on a range of wound care products, including cutting-edge wound dressings.
High-absorbent foam dressings, film, hydrogel, alginate, and hydrocolloid dressings are all part of the Tegraderm family of wound care products from 3M. Smith & Nephew offers a broad product line that includes, among other things, antimicrobial dressings, film, and alginate dressings.
Coloplast Corp., Derma Sciences Inc., Mölnlycke Health Care AB, and others are significant market participants. To take advantage of the potential market opportunities, these firms are investing in research and development notably to develop new products and expand their global presence.
Acquisition
Expansion
The market was valued at US$ 1.3 billion in 2022.
By 2033, the market is anticipated to produce US$ 2.57 billion.
The market is expected to yield US$ 1.38 billion in 2023.
From 2023 to 2033, the market is expected to rise at a robust CAGR of 6.4%.
Throughout the forecasted period, the category for acute wounds may expand at a rapid rate of 6.5%.
Over the forecast period, the povidone-iodine wound dressings segment is likely to expand at a 6.5% CAGR.
1. Executive Summary | Antimicrobial Wound Care Dressings Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033 5.3.1. Silver Dressings 5.3.2. Povidone-iodine Dressings 5.3.3. PHMB Dressings 5.3.4. Others 5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033 6.3.1. Chronic Wounds 6.3.1.1. Diabetic Foot Ulcers 6.3.1.2. Venous Leg Ulcers 6.3.1.3. Pressure Ulcers 6.3.1.4. Others 6.3.2. Acute Wounds 6.3.2.1. Surgical & Traumatic Wounds 6.3.2.2. Burns 6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-use 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By End-use, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-use, 2023 to 2033 7.3.1. Hospitals 7.3.2. Outpatient Facilities 7.3.3. Home Care 7.3.4. Research & Manufacturing 7.4. Y-o-Y Growth Trend Analysis By End-use, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By End-use, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. South Asia 8.3.5. East Asia 8.3.6. Oceania 8.3.7. MEA 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. The USA 9.2.1.2. Canada 9.2.2. By Product 9.2.3. By Application 9.2.4. By End-use 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product 9.3.3. By Application 9.3.4. By End-use 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product 10.2.3. By Application 10.2.4. By End-use 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product 10.3.3. By Application 10.3.4. By End-use 10.4. Key Takeaways 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. United Kingdom 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Europe 11.2.2. By Product 11.2.3. By Application 11.2.4. By End-use 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By Application 11.3.4. By End-use 11.4. Key Takeaways 12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Malaysia 12.2.1.3. Singapore 12.2.1.4. Thailand 12.2.1.5. Rest of South Asia 12.2.2. By Product 12.2.3. By Application 12.2.4. By End-use 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By Application 12.3.4. By End-use 12.4. Key Takeaways 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Product 13.2.3. By Application 13.2.4. By End-use 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By Application 13.3.4. By End-use 13.4. Key Takeaways 14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. Australia 14.2.1.2. New Zealand 14.2.2. By Product 14.2.3. By Application 14.2.4. By End-use 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product 14.3.3. By Application 14.3.4. By End-use 14.4. Key Takeaways 15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Product 15.2.3. By Application 15.2.4. By End-use 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product 15.3.3. By Application 15.3.4. By End-use 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Product 16.1.2.2. By Application 16.1.2.3. By End-use 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Product 16.2.2.2. By Application 16.2.2.3. By End-use 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Product 16.3.2.2. By Application 16.3.2.3. By End-use 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Product 16.4.2.2. By Application 16.4.2.3. By End-use 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Product 16.5.2.2. By Application 16.5.2.3. By End-use 16.6. United Kingdom 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Product 16.6.2.2. By Application 16.6.2.3. By End-use 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Product 16.7.2.2. By Application 16.7.2.3. By End-use 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Product 16.8.2.2. By Application 16.8.2.3. By End-use 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Product 16.9.2.2. By Application 16.9.2.3. By End-use 16.10. India 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Product 16.10.2.2. By Application 16.10.2.3. By End-use 16.11. Malaysia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Product 16.11.2.2. By Application 16.11.2.3. By End-use 16.12. Singapore 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Product 16.12.2.2. By Application 16.12.2.3. By End-use 16.13. Thailand 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Product 16.13.2.2. By Application 16.13.2.3. By End-use 16.14. China 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Product 16.14.2.2. By Application 16.14.2.3. By End-use 16.15. Japan 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Product 16.15.2.2. By Application 16.15.2.3. By End-use 16.16. South Korea 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Product 16.16.2.2. By Application 16.16.2.3. By End-use 16.17. Australia 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Product 16.17.2.2. By Application 16.17.2.3. By End-use 16.18. New Zealand 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Product 16.18.2.2. By Application 16.18.2.3. By End-use 16.19. GCC Countries 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Product 16.19.2.2. By Application 16.19.2.3. By End-use 16.20. South Africa 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Product 16.20.2.2. By Application 16.20.2.3. By End-use 16.21. Israel 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Product 16.21.2.2. By Application 16.21.2.3. By End-use 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product 17.3.3. By Application 17.3.4. By End-use 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Convatec, Inc. 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. B. Braun SE 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. 3M Company 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Smith & Nephew 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. Cardinal Health 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Coloplast Corp. 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Paul Hartmann AG 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Medline Industries 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. McKesson Corporation 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. Mölnlycke Health Care AB 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Antimicrobial Wound Care Dressings Market
